Great West Life Assurance CO Karyopharm Therapeutics Inc. Transaction History

Great West Life Assurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$1.79 - $4.59 $11,393 - $29,215	-6,365 Reduced 21.62%	23,069 $42,000
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $75,024 - $103,554	26,417 Added 875.6%	29,434 $114,000
Q4 2022 Feb 10, 2023	SELL	$2.48 - $5.93 $36,798 - $87,989	-14,838 Reduced 83.1%	3,017 $10,000
Q3 2022 Nov 01, 2022	BUY	$4.08 - $5.82 $72,848 - $103,916	17,855 New	17,855 $97,000
Q3 2020 Nov 17, 2020	SELL	$14.14 - $19.71 $1.65 Million - $2.3 Million	-116,827 Reduced 97.48%	3,017 $44,000
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $1.65 Million - $2.3 Million	116,827 Added 3872.29%	119,844 $1.75 Million
Q4 2019 Feb 11, 2020	BUY	$9.23 - $19.67 $27,846 - $59,344	3,017 New	3,017 $57,000
Q3 2019 Oct 25, 2019	SELL	$5.66 - $11.85 $32,182 - $67,379	-5,686 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$12.0 - $19.88 $48,336 - $80,076	4,028 Added 242.94%	5,686 $97,000
Q3 2017 Nov 09, 2017	BUY	$8.15 - $11.16 $13,512 - $18,503	1,658	1,658 $18,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $52.7M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.